AstraZeneca today announced that Marc Dunoyer is to join the company in the
newly created role of Executive Vice President, Global Portfolio & Product
Strategy.
Marc will be responsible for driving business strategy, including business development, mergers and acquisitions, portfolio and product strategies. His most critical priorities will be to bolster the core growth platforms and therapy areas through well executed business development initiatives and leadership of internal efforts.
